142P Early-phase clinical trials in gynaecologic malignancies: A 13-year single-center experience
Patients (pts) with advanced gynaecologic cancers often progress after standard therapies. Phase I trials provide access to innovative agents and may offer clinical benefit in heavily pretreated populations. We retrospectively evaluated outcomes of pts enrolled in phase I trials at a single academic center over 13 years.
Authors
- M. Imbimbo
- C. Sessa
- M. NERONE
- I. Colombo
- M. Iannace
- L. Tortola
- A. Stathis
- C. Cafaro Greco
- M. Pedrani
- V. Ricco
- A. Fossati
- E. Bisdomini
- A.P.A. Badellino
- A. Gagliano
- L. Pallavicini
- H-M. Lin
- A.R. Carvalho Mendonca
- E.A. Ciliberti
- N. Scahett
- D. Coppola
Institutions
- Institute of Oncology Research (CH)
Publication Details
- Journal
- ESMO Open
- Published
- 2026-07-01
- DOI
- https://doi.org/10.1016/j.esmoop.2026.108189
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00